Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: Protocol for Improvement of Therapy With Warfarin [Phase 3]

View source ↗

Summary

This document outlines a Phase 3 clinical trial protocol to improve warfarin therapy for atrial fibrillation. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: University of Pernambuco | Conditions: Atrial Fibrillation (AF) | Phase 3 | Status: ENROLLING_BY_INVITATION